STRO

STRO

USD

Sutro Biopharma Inc. Common Stock

$1.100+0.000 (0.000%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.100

Hoch

$1.110

Tief

$1.030

Volumen

0.07M

Unternehmensfundamentaldaten

Marktkapitalisierung

92.2M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.86M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $0.52Aktuell $1.100Hoch $5.17

Ähnliche Nachrichten

GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

Mehr anzeigen
Sutro Biopharma to Participate in Upcoming Investor Conferences
PR Newswire

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

Equity Insider News Commentary – Optimism in the field of oncology is on the rise, thanks to the National Institutes of Health's latest annual...

Mehr anzeigen
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Sutro Biopharma with a Neutral and maintains $2 price target.

Mehr anzeigen
HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target
GlobeNewswire

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

Mehr anzeigen
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025